Tenaya Therapeutics: TN-201 Isn't The Only Shot On Goal Targeting Heart Disease #Tenaya #Therapeutics #TN201 #Isn039t…
Tag: disease
Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease
PADOVA study showed numerical delay in motor progression and positive trends on multiple secondary and exploratory…